Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.5378
+0.0057 (1.06%)
May 28, 2025, 3:58 PM EDT
Elite Pharmaceuticals Employees
Elite Pharmaceuticals had 64 employees as of March 31, 2024. The number of employees increased by 11 or 20.75% compared to the previous year.
Employees
64
Change (1Y)
11
Growth (1Y)
20.75%
Revenue / Employee
$1,093,699
Profits / Employee
-$281,040
Market Cap
568.48M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| American Oncology Network | 1,914 |
| Longduoduo Company | 49 |
Elite Pharmaceuticals News
- 4 weeks ago - Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets - Newsfile Corp
- 3 months ago - Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line - Newsfile Corp
- 3 months ago - Elite Pharmaceuticals Inc (ELTP) Q3 2025 Earnings Call Highlights: Record Revenue Growth Amid ... - GuruFocus
- 3 months ago - Q3 2025 Elite Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
- 3 months ago - Elite Pharmaceuticals Inc Reports Q3 2025 Revenue of $14.4 Million Amid Shipment Delays - GuruFocus
- 3 months ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information - Newsfile Corp
- 3 months ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025 - Newsfile Corp
- 5 months ago - Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R) - Newsfile Corp